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A novel model to study renal myofibroblast formation in vitro. Interstitial fibrosis is a common hallmark of chronic
Background. In chronic renal disease, the decrease of excre- progressive diseases of parenchymous organs proceeding
tory renal function closely correlates with the extent of interstitial with an enhanced deposition of extracellular matrix. Infibrosis. A common feature of interstitial fibrosis is the occur-
the kidney, a close correlation between the extent of inter-rence of myofibroblasts, which are regarded as the predominant
stitial fibrosis and the decrease of organ function hascells in matrix synthesis. We studied the transformation of renal
fibroblasts into myofibroblasts in vitro as a model to elucidate been shown [1, 2]. Interstitial fibrosis proceeds, at least
the mechanisms underlying this process. in its initial stages, with an enhanced occurrence of myo-
Methods. Primary cultures of freshly isolated rat inner medul- fibroblasts. Myofibroblasts are presumed to play a piv-lary fibroblasts were established as reported previously. mRNA
otal role in the increased deposition of extracellular ma-expression of myofibroblast markers and interstitial collagens
trix components during interstitial fibrosis not only inwas examined by Northern blot and reverse transcriptase-poly-
merase chain reaction (RT-PCR). Phenotypic expression was the kidney [3–7], but also in the liver [8], and lung [9].
investigated by immunolabeling. Endogenous transforming The elucidation of the processes inducing the transfor-
growth factor-b (TGF-b) production was inhibited by addition
mation of fibroblasts to myofibroblasts and the alterationsof a neutralizing antibody or by TGF-b1 antisense oligodeoxy-
of the biology of the fibroblast associated with this trans-nucleotides (ODNs).
Results. Initially and during the first 36 hours, primary cul- formation are, therefore, of great interest. However, lit-
ture cells expressed neither a-smooth muscle actin nor desmin tle is known about the underlying mechanisms. One rea-
mRNA. From day 2 of primary culture, we observed a strong son for this is the lack of appropriate, well-characterized
increase in these mRNAs, as evaluated by RT-PCR, followed
in vitro models to study this question under defined con-by the phenotypic expression of these myofibroblast markers.
ditions. We have recently observed that freshly isolatedCollagen type I mRNA was first detectable from day 4 of
primary culture and showed a strong increase in its expression renal inner medullary fibroblasts spontaneously acquire
level during the following days, with phenotypic expression the phenotype of myofibroblasts in primary culture [10].
predominantly in myofibroblasts. The transformation rate of We have evaluated this transformation in detail for itsfibroblasts to myofibroblasts largely decreased in cocultures
suitability as an in vitro model system for the study ofwith collecting duct cells. This effect could be reversed by
myofibroblast formation. This model system permitted,reducing the seeding density. We examined in this system the
effect of TGF-b1 to define further its putative fibrogenic activ- under defined, serum-free culture conditions, the exami-
ity. However, neither the addition of exogenous TGF-b1 nor nation of the de novo expression of myofibroblast markers
the inhibition of endogenous TGF-b production showed any and collagen type I even from initially negligible mRNAsignificant effect on fibroblast transformation, suggesting that
levels as determined by reverse transcriptase-polymerasethis cytokine exerts its effects at other levels or requires a
chain reaction (RT-PCR). Furthermore, it was possiblecofactor.
Conclusions. We present a novel model to examine the de to modulate the transformation rate of fibroblasts simply
novo expression of myofibroblast markers and collagen type I by modifying the coculture conditions with collecting
in freshly isolated fibroblasts under defined conditions in pri-
duct cells.mary culture. This model could provide a strategy for the mo-
In this novel model, we studied the effect of trans-lecular characterization of myofibroblast formation and the
phenomena associated with this process. forming growth factor-b1 (TGF-b1), which supposedly
exerts its putative fibrogenic activity at various levels, such
as increasing matrix synthesis (for example, collagen andKey words: chronic renal disease, interstitial fibrosis, a-smooth muscle
actin, collagen type I, fibrosis, inner medulla, coculture. fibronectin), inhibition of matrix degradation, up-regula-
tion of the integrin expression, and chemoattraction ofReceived for publication October 22, 1999
fibroblasts and monocytes. An effect of TGF-b on theand in revised form July 6, 2000
Accepted for publication August 21, 2000 transformation of fibroblasts to myofibroblasts has also
been suggested [3, 11]. However, the exact actions ofÓ 2001 by the International Society of Nephrology
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this cytokine are poorly defined [3, 11–13]. Evaluating cle), and the cells were plated in culture wells. Cells ob-
tained from one rat were plated according to the follow-the effect of TGF-b1 on fibroblast transformation, we
observed that both the addition of exogenous and inhibi- ing scheme: inner medullary fibroblasts, three wells of a
96-well microtiter plate (or equivalent area), and innertion of endogenously produced TGF-b1 was without a
significant effect, suggesting that TGF-b1 is at least not medullary fibroblasts with collecting duct cells, six wells.
To reduce the seeding density of the fibroblasts cocul-a direct mediator of the transformation of fibroblasts to
myofibroblasts. tured with collecting duct cells, the cell suspension was
diluted 1:10 with culture medium prior to plating. PlatingThe presented model, which was initially virtually free
of myofibroblast marker-expressing cells, provides a new undiluted cells resulted in a confluent monolayer within
two days, whereas at a 1:10 dilution, they did not reachapproach to elucidate the mechanisms associated with
the transformation of renal fibroblasts to myofibroblasts confluency even after eight days in culture. Cell counting
was omitted since it was not possible to digest the collect-and the up-regulation of extracellular matrix production.
ing ducts to single cells as reported previously [14].
METHODS Cell culture
Cell isolation Isolated cells were kept in Dulbecco’s modified Eagle’s
medium (DMEM) and nutrient mix Ham’s F12 (1:1),Detailed procedures for the isolation and culture of
rat inner medullary fibroblasts have been published pre- supplemented with glutamine (2 mmol/L), sodium pyru-
vate (1 mmol/L), nonessential amino acids (1% vol/vol),viously [10]. In short, male Wistar rats (body weight 200
to 250 g; Harlan-Winkelmann, Borchen, Germany) were penicillin (50 U/mL), streptomycin (50 U/mL,) and 10%
fetal calf serum (all components from GIBCO, Eggen-sacrificed by cervical dislocation. Kidneys were immedi-
ately removed, and the inner two thirds of the inner stein, Germany). If a defined, serum-free medium was
used, serum was replaced by triiodothyronine (5 pmol/L),medulla were exactly excised. Tissue was placed in 290
mOsm ice-cold HEPES-Ringer’s buffer (composition in hydrocortisone (50 nmol/L), transferrin (5 mg/mL), bo-
vine insulin (5 mg/mL), and sodium selenite (10 nmol/L;mmol/L: 118 NaCl, 16 H-HEPES, 16 Na-HEPES, 14 glu-
cose, 3.2 KCl, 2.5 CaCl2, 1.8 MgSO4, 1.8 KH2PO4, pH 7.4), all components from Sigma, Deisenhofen, Germany).
Cells were grown on collagen-coated (20 mg/cm2, colla-minced with a razor blade, and subsequently incubated
for 75 minutes at 378C in the HEPES-Ringer’s buffer gen type VII; Sigma) supports.
containing in addition 0.2% (wt/vol) collagenase (CLS
Northern blotII, Cooper, Frankfurt, Germany) and 0.2% (wt/vol) hyal-
uronidase (Roche Diagnostics, Mannheim, Germany). Total cellular RNA was prepared from exactly excised
outer medulla, outer third (inner medulla outer part) orAfter completing the incubation procedure, the major-
ity of the collecting duct cells in suspension were removed inner two thirds of inner medulla (inner medulla inner
part) of rat kidney directly after scarification or from cul-through pelleting them by low-speed centrifugation at
28 3 g for two minutes. This centrifugation step was tured cells. The material was immediately lyzed in guanid-
ium isothiocyanate containing RLTt solution (additionrepeated twice. The cells in the pellet consisted of ap-
proximately 80% inner medullary collecting duct (IMCD) of 1% vol/vol b-mercaptoethanol prior to use) and further
isolated by a silica gel membrane-based technique with acells, but also of the other inner medullary cell types, in
particular fibroblasts, as outlined later in this article. This RNeasy-Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. Total RNA (10 to 20 mg/lane)fraction was used for the coculture experiments of the
inner medullary fibroblasts with the collecting duct cells. was separated on an 1% agarose gel under denaturating
conditions, transferred to a nylon membrane (AmershamThe supernatants of the first two low-speed centrifuga-
tions containing the majority of interstitial cells were then Life Science, Cleveland, OH, USA), and immobilized by
ultraviolet cross-linking. The filter was prehybridized (45completely purified from IMCD cells by the use of beads
coated with the lectin Dolichos Biflorus agglutinin (DBA) minutes at 688C) in QuikHybt hybridization solution
(Stratagene, Heidelberg, Germany) and subsequentlyas reported previously [14]. The cell suspension was then
placed on the top of a continuous Nycodenz [5-(N-2,3- hybridized in that solution containing the radiolabeled
cDNA and 100 mL salmon sperm DNA (10 mg/mL,dihydroxypropylacetamide)-2,4,6,-tri iodine N9-bis(2,3-
dihydroxypropyl)-isophtalamide; Nycomed A J, Oslo, Nor- denaturated 10 minutes at 958C). The cDNA probes had
been previously labeled with a-32-P dCTP by random-way] gradient with a density of approximately 1.052 to
1.093 g/cm3 and spun at 1500 3 g for 45 minutes at 48C. priming (Roche Diagnostics). The probes detecting
pro-a1 (I) collagen and pro-a1 (III) collagen had beenAfter centrifugation, interstitial cells were mostly enriched
in that fraction with a density of 1.081 to 1.093 g/cm3. The previously characterized by Chu et al [15, 16] and that
detecting a-smooth muscle actin (a-SMA) by SchwartzNycodenz was removed by two centrifugation steps with
culture medium (composition discussed later in this arti- et al [17]. The latter probe also detected b-actin. Further-
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more, a cDNA probe exclusively recognizing b-actin was a-Smooth muscle actin: 59-AGG GAG TAA TGG
TTG GAA TGG G-39 (forward) and 39-GGA GTAconstructed from the product of the b-actin RT-PCR,
which is described in the following section. After hybrid- CGG TAC GCA GA-59 (reverse) (product size 412 bp).
Desmin: 59-GAA ATC CAA CTG AGA GAA GAAization for two hours at 688C, the filter was washed 15
minutes at room temperature in 2 3 standard saline G-39 (forward) and 39-GAA GAG ACG AGA GTT
GAA GG-59 (reverse) (product size 697 bp).citrate (SSC)/0.1% sodium dodecyl sulfate (SDS), 15
minutes at 608C in 2 3 SSC/0.1% SDS, 30 minutes at Procollagen type I: 59-CTT CGT GTA AAC TCC
CTC C-39 (forward) and 39-CAC TGG TTT TTG GTT608C in 1 3 SSC/0.1% SDS, and finally 30 minutes in
0.2 3 SSC/0.1% SDS. After washing, the membrane was TTC AC-59 (reverse) (product size 224 bp).
Procollagen type III: 59-GCG GCT TTT CAC CATkept in plastic bags and finally exposed to x-ray films
(Kodak BioMax MR; Eastman Kodak, Rochester, NY, ATT AG-39 (forward) and 39-CTT TGG CCT CTT TGT
ACG-59 (reverse) (product size 266 bp).USA) at 2708C. For rehybridizations, the probe was
removed by boiling the membrane in water containing Transforming growth factor-b1: 59-CAA CGC AAT
CTA TGA CAA AAC C-39 (forward) and 39-CTC TGCTris-ethylenediaminetetraacetic acid (EDTA), pH 7.4,
for three minutes. CTT ATG TCC CGA AA-59 (reverse) (product size
301 bp).
Reverse transcriptase-polymerase chain reaction b-Actin: 59-GTG GGG CGC CCC AGG CAC CA-39
(forward) and 39-CTT TAG CAC GCA CTG TAA TTCTotal cellular RNA was prepared as reported for the
Northern blot studies. One microgram of RNA was de- CTC-59 (reverse) (product size 538 bp).
The PCR product was separated on a 1% agarosenaturated at 708C for 10 minutes in the presence of 0.5 mg
oligo-(dT)12–18 (GIBCO BRL) and cooled on ice for one gel, stained with ethidium bromide (0.5 mg/mL), and
photographed.minute. The RNA was reversed transcribed in a final
volume (20 mL) of 1 3 PCR buffer (20 mmol/L Tris-HCl, Semiquantitative evaluation of the respective mRNA
expression levels were performed by comparison to thatpH 8.4, 50 mmol/L KCl), 2.5 mmol/L MgCl2, 10 mmol/L
dithiothreitol, 0.5 mmol/L of each desoxynucleoside tri- of b-actin (Molecular Analyst Software; Bio-Rad, Her-
cules, CA, USA).phosphate (dNTP) and 200 U of SuperscriptE reverse
transcriptase (GIBCO BRL). The reaction mixture was
Sequencingincubated at 428C for 50 minutes. Reactions were termi-
nated by heating the sample to 708C for 15 minutes. The identity of the amplified cDNA was confirmed by
sequencing. Cycle sequencing with IR-labeled primersRNA was degraded by addition of 2 U RNase H at 378C
for 20 minutes. was performed with a Thermo Sequenase Cycle Se-
quencing Kit (Amersham Life Science) according to theFive microliters of cDNA product was amplified by
PCR in 50 mL final volume of 10 mmol/L Tris (pH 9.0), 50 manufacturer’s instructions. The product was separated
on a 6% polyacrylamide gel and analyzed with an auto-mmol/L KCl, 1.5 mmol/L (a-SMA, desmin, procollagen
type I, TGF-b1), 2.0 mmol/L (procollagen type III), or mated sequencer (Li-Cor 4000; MWG-Biotech).
2.5 mmol/L (b-actin) MgCl2, 200 mmol/L dNTP, 20 pmol
Antisense-oligodeoxynucleotides for TGF-b1each primer, and 1.25 U Taq-Polymerase (Pharmacia,
Freiburg, Germany) in a Perkin Elmer thermocycler Two sets of TGF-b1 antisense oligodeoxynucleotides
(ODNs) were tested. (1) ODNs with C5-propyne modi-(Gene Amp 2400; Perkin Elmer, Norwalk, CT, USA).
Heating to 948C for five minutes was followed by 30 fied pyrimidines (p) and phosphorothioate (PTO) link-
ages as described by Wagner [18]. This modification iscycles (b-actin, 25 cycles) of 948C for 50 seconds, 508C
(b-actin) or 608C (a-SMA, desmin, procollagen type I reported to combine long intracellular survival time (due
to PTO-linkage) with high RNA binding efficiency (pro-and III) for one minute, or 558C (TGF-b1) for 90 seconds,
728C for 30 seconds, and finally one cycle at 728C for pyne modification). The following ODNs were synthe-
sized by Eurogentec (Seraing, Belgium): antisense 59-GAAseven minutes. In preliminary experiments, each sample
was amplified using various numbers of cycles (b-actin G(pC)A G(pU)A G(pU)(pU) GG(pU) A(pU)(pC) (pC)A-39
and, as control, reverse 59-A(pC)(pC) (pU)A(pU) GG(pU)for 22, 25, 28, 30 cycles; other primers for 25, 28, 30, 33
cycles) to ensure that all PCR determinations fell within (pU)GA (pC)GA AG-39. The antisense ODN was di-
rected against nucleic acids 1838 to 1856 from the trans-the linear amplification range. Thus, it was possible to
ensure that semiquantitative estimates were derived only lation start site of the TGF-b1 mRNA (GenBank X52498)
corresponding to the coding region for the first sevenfrom determinations in the range in which product abun-
dance was proportional to the amount of initial template. amino acids of the N-terminus of the protein. (2) ODN
with a phosphorothioate backbone was the second tested:Primers were designed from the published cDNA se-
quences and were obtained from MWG-Biotech (Ebers- antisense 59-CCC CGA GGG CGG CAT GGG GGA-39
and, as control, reverse 59-AGG GGG TAC GGC GGGberg, Germany):
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AGC CCC-39 (MWG Biotech). The antisense ODN was bated with the FITC- or rhodamine-labeled lectin dis-
solved in PBS at a concentration of 30 mg/mL for 30directed against the translation start site of TGF-b1
mRNA (nucleotides 26 to 114) [19]. As this sequence minutes at room temperature in the dark, followed by
a PBS-washing step. Nuclei were counterstained withis relatively deficient in pyrimidines, propyne modifica-
tion of pyrimidines was not expected to have much effect. 49,6-diamidino-2-phenylindole (DAPI; Sigma; 5 mg/mL
stock in methanol, 1:100 diluted with PBS before use) forTo enhance transfection perfomance, Cytofectin GSVe
(GlenResearch, Sterling, VA, USA) was used. Cytofec- 15 minutes at 378C. To prevent bleaching, slides were
finally embedded with Mowiol (Calbiochem, La Jolla,tin GSVe and ODNs were each prediluted in 200 mL
of serum-free culture medium (SFM). Prediluted GSVe CA, USA), 10 wt/vol% in 25% glycerol (pH 8.5 with Tris/
HCl) and evaluated with a Zeiss fluorescence-microscopeand ODNs were mixed and incubated for 10 minutes at
room temperature before diluting to the final working (Oberkochen, Germany). The following antibodies and
lectins were used (dilution in brackets): anti–a-SMA (di-concentration. In preliminary experiments with subcul-
tured fibroblasts, the optimal conditions for inhibition rected against the a-actin isoform of smooth muscle,
1:20; Roche Diagnostics), antidesmin (1:20; Roche Diag-of endogenous TGF-b1 production by antisense ODN
had been determined. ODNs with C5-propyne–modified nostics), anticollagen type I (Sigma), anti–TGF-b1, rec-
ognizing an epitope corresponding to an amino acid se-pyrimidines were tested in a concentration range be-
tween 3 and 30 nmol/L, ODNs with a phosphorothioate quence mapping at the carboxy terminus of the precursor
form (Santa Cruz Biotechnology, Santa Cruz, CA, USA),backbone between 10 nmol/L to 10 mmol/L, and cytofec-
tin between 1 and 9 mg/mL. Optimal effects were ob- antifactor VIII-related antigen (1:20 “Clotimmun”; Beh-
ringwerke, Marburg, Germany), Bandeiraea Simplici-tained using C5-propyne modified antisense ODN and
cytofectin at concentrations of 20 nmol/L and 2 mg/mL, folia-1 lectin (BSL-1, 30 mg/mL; Sigma).
Recombinant TGF-b1 as well as a pan-specific TGF-brespectively. These conditions were chosen for the exper-
iments. Inner medullary fibroblast cultures were washed antibody to neutralize the biological activity of endoge-
nously produced TGF-b were obtained from R&D Sys-two times with serum-free medium before transfection.
Primary cultures were transfected immediately after tems.
plating in serum-free medium.
Quantitative evaluation of the immunohistological
staining patternTGF-b1 enzyme-linked immunosorbent assay
Concentration of TGF-b1 in cell culture supernates Phenotypic transformation of fibroblasts to myofi-
broblasts was evaluated as reported previously [10]. Thewas measured with a specific enzyme-linked immunosor-
bent assay (ELISA) system (Quantikinee; R&D Sys- expression of phenotypic markers was measured using
the following procedure: The slides were independentlytems, Minneapolis, MN, USA) exactly according to the
manufacturer’s instructions. To activate latent TGF-b1 examined by two persons at a magnification of 3400 in
triple immunofluorescence (FITC/rhodamine/UV). Eval-to immunoreactive TGF-b1 detectable by the immuno-
assay, samples were first acidified by 1 mol/L HCl and uating the DAPI-positive nuclei with the ultraviolet fil-
ter, an area with a representative cell density was placedneutralized after 10 minutes by adding 1.2 mol/L NaOH/
0.5 mol/L HEPES. The minimum detectable dose of within a frame of 100 3 100 mm, outlined in the ocular.
By switching to the filters for FITC or rhodamine fluo-TGF-b1 was 7 pg/mL.
rescence, the absolute numbers of fluorescing cells within
Immunohistochemistry this area were counted. Five representative areas were
counted per sample. The results of the two examinersCryosections or cells cultured on glass cover slides
were washed with phosphate-buffered saline (PBS) and revealed a very high degree of conformity without any
significant differences, and therefore the numbers werefixed with acetone (2208C, 15 min) or 100% methanol
(48C, 15 minutes) for factor VIII staining. For TGF-b pooled. As reported previously, the myofibroblast-like
cells were characterized by their weak positivity for thestaining, tissue denaturation was performed by incuba-
tion in acid urea (6 mol/L urea/0.1 mol/L glycine HCl lectin BSL-1 [10]. They expressed to a very high degree
the myofibroblast markers a-SMA and/or desmin. Inbuffer, pH 3.5) for one hour as reported by Yoshioka
et al [20], in order to activate latent TGF-b to immunore- contrast, the fibroblasts and also the endothelial cells
were strongly positive for BSL-1. The transformationactive TGF-b. Specimens were incubated with the re-
spective antibodies for 60 minutes at 378C. Substitution rate of fibroblasts to weak BSL-1–positive myofibroblast-
like cells was calculated as the percentage of the weakof the primary antibody with an irrelevant antibody of
the same immunoglobulin type served as control. Sam- BSL-1–positive cells of all BSL-1–positive cells. In pre-
liminary experiments, we had examined under all experi-ples were washed with PBS and stained with an appro-
priate FITC- or rhodamine-labeled second antibody for mental conditions used, its possible impact on the num-
ber of the strong BSL-1–positive endothelial cells by60 minutes at 378C. For lectin staining, slides were incu-
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double labeling with the lectin BSL-1, and the endothe-
lial cell marker factor VIII-related antigen. The number
of endothelial cells remained unchanged in comparison
to the control under different experimental conditions.
Statistical analysis
Results are expressed as mean 6 SEM unless stated
otherwise. Because of the skewed distribution of the
data, these were analyzed by nonparametric tests for two
factors using rank procedures [21] instead of analysis of
variance (ANOVA) methods. For pairwise comparisons,
the Mann–Whitney U test was performed. In follow-up
tests the a levels were adjusted by using the Bonferroni-
Holm procedure. A P value #0.05 was considered statis-
tically significant.
RESULTS
Expression of myofibroblast markers and interstitial
collagens during the transformation of fibroblasts
Fig. 1. Expression of the interstitial collagens types I and III mRNAto myofibroblasts
and of the myofibroblast marker a-smooth muscle actin (a-SMA) by
Northern blot. (A) Examination of collagen type I and collagen typeTo evaluate the early events during the transformation
III expression: Total RNA (10 mg/lane) was analyzed by Northern blotof fibroblasts to myofibroblasts, we examined mRNA
with cDNA probes for pro-a1 (I) collagen and was then stripped and
expression of the myofibroblast marker a-sma and that reprobed for pro-a1 (III) collagen, followed by b-actin. No significant
expression was observed in material derived from the outer medullaof the interstitial collagens types I and III as components
(OM) and inner medulla (IM) of nonfibrotic rat kidney. In contrast,
of the extracellular matrix. As shown in Figure 1, in in subcultured (passage 4: P4) inner medullary fibroblasts, a clear
expression of both parameters was observed. (B) A similar expressionNorthern blot analysis with material derived both from
pattern as in the previous panel was observed for a-smooth musclethe outer and inner medulla of nonfibrotic rat kidneys,
actin (a-SMA). Both the OM and IM of nonfibrotic rat kidney were
neither mRNA encoding collagen types I and III as com- negative, whereas a strong signal in subcultured inner medullary fibro-
blasts (P4) was observed. This cDNA probe recognized both a-smoothponents of the extracellular matrix nor the myofibroblast
muscle actin and b-actin mRNA, which served as control.
marker a-SMA was detectable. In contrast, subcultured
inner medullary fibroblasts, a high percentage of which
exhibited the myofibroblast phenotype, showed a strong
Examination of the time course of the expression ofmRNA expression of all of these parameters. Since
the aforementioned parameters in cultureNorthern blot analysis was not sensitive enough for the
Freshly isolated fibroblasts during the first 36 hoursevaluation of the transition of fibroblasts to myofibroblasts
in culture showed a similar mRNA expression patternin primary culture, we examined mRNA expression by
as the tip of the inner medulla in situ. From day 2 onward,RT-PCR (Fig. 2). Using this technique, the myofibroblast
a strong increase in the expression of a-SMA was ob-markers a-SMA and desmin, and the interstitial colla-
served. A similar time course was observed for the ex-gens type I and III could be clearly detected in the outer
pression of desmin. In contrast, the mRNA expressionmedulla as well as in the outer third of the inner medulla.
of collagen type I increased only from day 4 onward,In contrast, in the inner two thirds of the inner medulla,
whereas collagen type III was expressed from the start
which are free of constitutively myofibroblast marker-
of the primary culture. A semiquantitative assessment
expressing cells like pericytes [10], no significant expres- of the expression levels of the respective mRNAs at
sion of a-SMA mRNA and desmin mRNA was detect- various time points as compared with the housekeeping
able by this technique. Also, expression of collagen type b-actin is shown in Figure 3.
I mRNA was negligible in the inner medulla, whereas The expression of the myofibroblast markers and col-
a clear signal was obtained for collagen type III mRNA. lagen type I at the protein level, evaluated by immuno-
To prevent contamination with cells that constitutively staining, followed that of the respective mRNAs with a
express myofibroblast markers, cells for the in vitro stud- delay of about 24 hours (data not shown). The expression
ies were isolated from the inner two thirds of the inner pattern of collagen type I by double immunostaining with
a-SMA or the lectin BSL-1 is shown in Figure 4. Exclu-medulla.
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Fig. 2. Detection of mRNA expression of the
myofibroblast markers a-SMA and desmin
and of the interstitial collagens types I and III
in different areas of the kidney. Symbols are:
( ) a-SMA; (j) desmin; ( ) collagen type I;
( ) collagen type II. Examination of mRNA
expression of the myofibroblast markers
a-SMA and desmin and of the interstitial col-
lagens type I and III in different areas of the
kidney by RT-PCR showed that in the outer
medulla all, four parameters were clearly ex-
pressed. Because of the occurrence of myofi-
broblast marker expressing pericytes, expres-
sion was also seen in the outer third of the
inner medulla but not in the inner parts of
the inner medulla; the latter was negative for
the myofibroblast markers a-SMA and desmin
mRNA by RT-PCR amplification. In contrast
to collagen type III, which was detectable in
material derived from all areas of nonfibrotic
rat kidneys, the expression of collagen type I
mRNA in the inner medulla was negligible.
Semiquantitative evaluation in relation to
b-actin (N 5 5 per data point).
be performed on cells cultured in a defined, serum-free
medium (SFM). For example, culture medium with 10%
fetal calf serum (FCS) contained about 1 ng/mL TGF-b1,
as determined by ELISA. Cells cultured from plating in
a defined, serum-free or 0.5% FCS containing medium
transformed to myofibroblasts. Growth characteristics
and transformation rates were similar to that of fibro-
blasts cultured in medium with 10% FCS. In contrast,
subcultured inner medullary fibroblasts required serum
for at least 36 hours after splitting and seeding in a new
culture flask; otherwise, a high portion of cells did not
attach. The experiments on freshly isolated fibroblasts
reported in the following were usually performed both
in serum-free and serum-containing medium, and no dif-Fig. 3. Time course of the mRNA expression of the myofibroblast
markers a-SMA (r) and desmin (j), and of the interstitial collagens ferences were observed. The results of the cells cultured
type I (n) and type III (3) by inner medullary fibroblasts in primary in serum-free medium are shown.culture. As in the inner two thirds of the inner medulla in situ, expres-
sion of the myofibroblast markers a-sma and desmin and of collagen
Effect of a coculture with inner medullary collectingtype I was negligible in freshly isolated cells and during the first two
days in culture. In the following days, a strong increase of the expression duct cells on the transformation of fibroblasts
of a-sma and desmin was observed, followed by that of collagen type
to myofibroblastsI with a delay of about two days. In contrast, collagen type III was
expressed from the beginning. Semiquantitative evaluation in relation- The effects of a coculture of fibroblasts with IMCDship to b-actin (N $ 5 per data point) is shown.
cells on the transformation rate of fibroblasts to myofi-
broblasts, given as the percentage of weak BSL-1–
positive myofibroblasts of all BSL-1–positive cells as out-
sively the a-SMA-positive and BSL-1 weakly–positive
lined in the Methods section, are shown in Figures 5 andmyofibroblasts, but not the BSL-1 strongly–positive fibro-
7. In coculture with BSL-1–negative collecting duct cells,blasts nor the other inner medullary cell types exhibited a
the transformation rate was significantly (P , 0.0001)significant collagen type I expression in culture, suggesting
reduced as compared with fibroblasts without this cocul-that the myofibroblasts are predominantly responsible
ture. Simply by reducing the seeding density of the cellfor an enhanced production of extracellular matrix.
suspension under the coculture condition by a factor of
Culturing cells in a defined, serum-free medium 10 at plating, a significant (P , 0.0001) increase of the
transformation rate to values similar to those for notTo define the factors involved in the transformation
of fibroblasts to myofibroblasts exactly, studies should cocultured fibroblasts was observed.
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Fig. 4. Phenotypic expression of collagen type I by myofibroblasts in primary cultures of the inner medulla. Double staining of day 8 PCs of inner
medullary fibroblasts with anticollagen type I and Bandeiraea Simplicifolia-1 lectin (BSL-1; A–C) or the myofibroblast marker anti–a-SMA (D–F)
is shown. Collagen type I (B and E, FITC filter) was phenotypically expressed only in the myofibroblasts (marked by opened arrows), characterized
by their weak reactivity with the lectin BSL-1 (A, rhodamine filter) and the expression of a-SMA (D, rhodamine filter). In contrast, the strong
BSL-1–positive fibroblasts (marked by closed arrows) and the BSL-1–negative cells (C and F, DAPI staining of the nuclei) did not express collagen
type I. The morphology of the BSL-1–reacting cells had been extensively characterized in previous work [10]. Magnification 3650.
Evaluation of the role of TGF-b on the Neutralizing the effect of endogenously produced TGF-b1
transformation of fibroblasts to myofibroblasts Since various cell types of both epithelial and mesen-
chymal origin are reported to produce TGF-b1, we wereTo define the putative fibrogenic effects of TGF-b
further, we examined its effect on the transformation of interested in studying the role of endogenously produced
TGF-b1 on fibroblast transformation. In SFM of subcul-fibroblasts. Since it is well known that TGF-b exerts
differential effects on the same cell type under different tured fibroblasts, to a large extent consisting of myofi-
broblasts, significant amounts of TGF-b1 could be detectedexperimental conditions, we examined its effects on fi-
broblasts exhibiting both high and low transformation (3.80 6 0.27 ng TGF-b1 per mL, N 5 7). Immunostaining
with anti–TGF-b revealed that predominantly the myo-rates to myofibroblasts.
fibroblasts expressed TGF-b (data not shown).
Addition of TGF-b1 to the culture medium In contrast, the TGF-b1 content in the primary culture
medium was below the detection limit of the assay, al-First, the effect of TGF-b1 (0.5 and 5 ng/mL), added
though mRNA encoding for TGF-b could be detectedto the medium from the start of the culture, was exam-
by RT-PCR. Immunostaining with an anti–TGF-b1 anti-ined on the phenotypic transformation of fibroblasts to
body suggested a slight expression of the collecting ductmyofibroblasts. However, as shown in Figure 5, there was
by epithelial cells and also by some of the myofibroblasts,no significant impact of TGF-b1 on the transformation
but not by fibroblasts. To evaluate the role of endoge-rate cultured either with or without collecting duct cells.
The effect of TGF-b1 on the mRNA expression of nously produced TGF-b1, cells were cultured in the pres-
ence of an antibody to neutralize the biological activitythe myofibroblast markers a-SMA, desmin, and collagen
type I as a marker for the production of extracellular of TGF-b (30 mg/mL). When tested in various culture
conditions, without coculture or in coculture with collect-matrix was also studied. Similar to the lack on the pheno-
typic transformation, no significant effect of TGF-b1 on ing duct cells at different seeding densities, the neutraliz-
ing antibodies had no effect on the transformation ratethese parameters was seen (Fig. 6).
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enhanced production of extracellular matrix under this
pathologic condition [7, 9]. Examination of myofibro-
blast formation is hampered by the lack of appropriate
in vitro models. In the present study, we evaluated the
suitability of the transformation of freshly isolated inner
medullary fibroblasts as a model to study the mechanisms
underlying this phenomenon in vitro. This model renders
several interesting aspects. Initially, it is virtually free
of constitutively myofibroblast markers expressing cells.
mRNA expression levels of the myofibroblast markers
a-SMA and desmin were negligible even by RT-PCR.
Therefore, the appearance of new cellular proteins un-
Fig. 5. Effect of transforming growth factor-b (TGF-b) or of a neu- equivocally reflects phenotypic modulation rather than
tralizing antibody against TGF-b on the phenotypic transformation of a selection of proliferating cells constitutively expressing
fibroblasts to myofibroblasts. Both the addition of TGF-b [(j) 0.5 or
the proteins. Second, expression of collagen type I mRNA( ) 5 ng/mL] and of a neutralizing antibody against TGF-b ( ; 30
ng/mL) to a serum-free culture medium ( ; control) was without also was not detectable in freshly isolated fibroblasts,
significant effect on the transformation of fibroblasts to myofibroblasts, allowing an examination of the mechanisms underlying
regardless of the culture condition of the fibroblasts. In contrast, the
the up-regulation of this component as a parameter ofculture condition had a significant impact on the phenotypic transfor-
mation to myofibroblasts. In coculture with collecting duct (CD) cells, extracellular matrix production by myofibroblasts. It fol-
the transformation rate was significantly reduced (P , 0.0001) com- lowed that of the myofibroblast markers by about 48 hours
pared with inner medullary fibroblasts cultured without collecting duct
and was predominantly localized to the myofibroblasts,cells (IMF). Simply by reducing the seeding density of the cells in
coculture by a factor of 1:10 at plating (CD 1:10), a significant increase demonstrating that the fibroblasts, which transformed to
of the transformation rate was observed (P , 0.0001). The transforma- myofibroblasts, indeed exhibit a strong up-regulation of
tion was evaluated as the percentage of weak BSL-1–positive myofi-
extracellular matrix production. Third, the transforma-broblasts to all BSL-1–positive cells. Results of day 5 primary cultures
are shown (NS 5 not significant, P 5 P value, N 5 16 per condition). tion of fibroblasts occurred regardless of whether these
were cultured from plating in a serum-free or serum-
containing medium. Examination of fibroblast transfor-
mation was therefore possible under a fully defined me-
of fibroblasts to myofibroblasts (Fig. 5). As shown in dium. In contrast, subcultured inner medullary fibroblasts
Figure 6, anti–TGF-b-neutralizing antibody had no ef- required serum after splitting and seeding, suggesting a
fect on the mRNA expression of the myofibroblast mark- difference in the growth behavior of freshly isolated and
ers a-SMA and desmin or collagen type I. subcultured fibroblasts. Furthermore, transformation of
Furthermore, using TGF-b1 antisense oligonucleo- fibroblasts depended on the culture conditions. The trans-
tides, we examined the effect of inhibiting endogenous formation rate of fibroblasts to myofibroblasts was signifi-
TGF-b1 production on the transformation rate. In sub- cantly reduced if these were cocultured with collecting
cultured fibroblasts using C5-propyne–modified antisense duct cells. Simply decreasing the cell density of the cocul-
ODN and cytofectin at concentrations of 20 nmol/L and tured cells at plating significantly increased the transfor-
2 mg/mL, respectively, endogenous TGF-b1 production mation rate of fibroblasts to myofibroblasts to levels simi-
was reduced by 58.1 6 5.3% (N 5 12) compared with lar to those observed in fibroblasts not cultured with
reverse ODN as the control. These conditions were ap- collecting duct cells. This allowed the examination of
plied to the antisense experiments in primary cultures. fibroblasts under both low and high transformation rates,
As shown in Figure 7, in experiments culturing fibro- corresponding to a high percentage of nontransformed,
blasts from the start of the primary culture in the pres- “nonactivated” fibroblasts or transformed, “activated”
ence of TGF-b1 antisense-ODN, no significant effect on fibroblasts, respectively. Taking into account that the
the transformation rate of fibroblasts was noted com- stage of transformation is of basic importance in evaluat-
ing the effect of a certain “factor” or substance on thepared with reverse ODN as the control. The transforma-
same fibroblast type, since these may vary considerablytion rate of fibroblasts cocultured with collecting ducts
depending on the stage of differentiation [22], the follow-both at high and low densities also was not affected by the
ing actions of TGF-b are discussed. Elucidation of theinhibition of TGF-b1 production with antisense ODN.
mechanisms responsible for the different transformation
rates under these reported culture conditions might
DISCUSSION greatly contribute to the understanding of factors regu-
Myofibroblasts represent a hallmark of interstitial fi- lating the phenotype of fibroblasts. However, their clari-
brosis in the kidney as well in other parenchymous or- fication was beyond the scope of our current study. Since
conditioned medium from collecting duct cells had nogans, and are considered to be the major source for the
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Fig. 6. Effect of the addition of TGF-b or of
a neutralizing antibody against TGF-b to the
culture medium on the mRNA expression of
the myofibroblast markers a-SMA and des-
min and collagen type I as marker for the
extracellular matrix. (A) Addition of TGF-b
(5 ng/mL) to the SFM was compared with the
controls without a significant effect either on
the mRNA expression of the myofibroblast
markers or collagen type I. No effect of TGF-b
was observed, regardless of whether the inner
medullary fibroblasts (IMF) were cultured
without or with collecting duct cells. Symbols
are: ( ) without TGF-b; (j) with TGF-b. (B)
Addition of a neutralizing antibody against
TGF-b to the serum-free culture medium in
order to antagonize endogenous TGF-b pro-
duction was also without a significant effect
on the aforementioned parameters in IMF cul-
tured both with and without collecting duct
cells. Symbols are: ( ) without anti-TGF-b;
(j) with anti-TGF-b. Results of day 4 primary
cultures are shown. (N 5 4 per condition).
effect on the transformation rate (unpublished data), human fibroblast cell lines, where a significant effect on
cell proliferation could be observed (abstract; Strutz etthe present evidence suggests cell–cell contacts as an
important factor regulating the phenotype of fibroblasts al, J Am Soc Nephrol 10:A581, 1999). Furthermore, in
the model reported here, TGF-b clearly stimulated thein this experimental setup. Such a mechanism also had
been suggested in dermal fibroblasts by Masur et al, who assembly of fibronectin into fibrillar matrix in myofi-
broblasts (unpublished data), a phenomenon likewiseobserved a cell density-dependent transformation rate
to myofibroblasts [23]. observed in embryonic skin fibroblast by Allen-Hoff-
mann, Crankshaw, and Mosher [25], suggesting that thisIn this model, we have evaluated the effect of TGF-b
on fibroblast transformation to define its putative fibro- cytokine exerts effects at least at other levels. Since fi-
broblasts, especially myofibroblasts [3], as confirmed ingenic activity at this level. In mammals, three isoforms
of TGF-b (b1, b2, and b3) have been identified, with this study, and also collecting duct cells [26] are a source
of TGF-b1, we were especially interested in evaluatingTGF-b1 as the predominant isoform expressed in inter-
stitial fibrosis [11, 12, 19, 24]. However, the addition of the role of the intrinsic TGF-b activity on the transforma-
tion of fibroblasts to myofibroblasts, which to our knowl-TGF-b1 to the cultures in different doses had no signifi-
cant effect on the transformation rate, although TGF-b edge had yet to be studied. Two commonly used ap-
proaches to antagonize endogenous TGF-b production,and anti–TGF-b were applied under exactly the same
conditions as in parallel studies in our laboratory on the addition of a TGF-b neutralizing antibody or anti-
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address questions related to this item. Also, as yet un-
identified cofactors have been suggested to explain the
effects of TGF-b modified by serum on the transforma-
tion of fibroblasts or mesangial cells [28, 29]. It is conceiv-
able that under conditions or cofactors as yet untested
in this model, this cytokine might have an effect on trans-
formation, allowing its further characterization in this
case. Nevertheless, our results provide clear evidence
that the transformation of fibroblasts to myofibroblasts
is not critically dependant on TGF-b1.
This novel assay allows examination of the expression
of the myofibroblast markers and collagen type I in cells,
Fig. 7. Effect of TGF-b antisense oligodeoxynucleotides (ODN) on
originally from the same generation, in vivo in a systemthe phenotypic transformation of fibroblasts to myofibroblasts. Cultur-
ing cells in the presence of TGF-b antisense ODN ( ) had no signifi- that initially is virtually free of myofibroblasts. There-
cant effect on transformation rate of the fibroblasts to myofibroblasts fore, this assay will permit the study not only of further
compared with reverse ODN (j) as a control independent of the
aspects of the previously mentioned items, but many ques-culture conditions. In contrast, the culture conditions had a significant
impact on the transformation rate (IMF, inner medullary fibroblasts tions related to the modulation of fibroblast phenotype
without collecting duct cells; CD, coculture with collecting duct cells; and the resulting changes of the biochemical properties
CD 1:10, cells diluted by a factor of 10 at plating compared with CD).
of this cell type under largely defined conditions. A veryThe transformation was evaluated as the percentage of weak BSL-
1–positive myofibroblasts to all BSL-1–positive cells. Results of day 5 interesting aspect will be the clarification of the role of
primary cultures are shown (NS 5 not significant, P 5 P-value, N 5 cell–cell interactions, as suggested by our present study.8 per condition).
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